周五值得关注的5只股票：JPM、BLK、STT等

U.S. stock index futures on Friday pointed to a lower open, with the spotlight squarely on quarterly reports from major lenders and financial firms. Here are some stocks to watch on Friday: 

• U.S.-listed shares of Coupang (CPNG) jumped almost 9% ahead of market open. The South Korean e-commerce giant announced a massive 58% hike for its monthly membership fees to 7,890 won ($5.71). This was Coupang's (CPNG) first membership fee hike since 2022. Morgan Stanley called the development a positive surprise for investors and believes it will provide fresh momentum for shares. Coupang (CPNG) had around 14M members as of last year, which means monthly membership revenue could increase to 110.5B won (nearly $80M) from 69.9B won with the fee hike.
• JPMorgan (JPM) stock dipped more than 3.5% in pre-market trading, after the number one U.S. bank by assets provided annual net interest income (NII) guidance that came in below expectations. JPMorgan (JPM) now sees NII, excluding markets, of $89B, slightly higher than its prior outlook of ~$88B but below the Visible Alpha consensus of $90.4B. JPMorgan (JPM) top boss Jamie Dimon noted that "many economic indicators" continued to be favorable, but warned of "uncertain forces" going forward such as "a large number of persistent inflationary pressures, which may likely continue." See how JPM performed in charts.
• Shares of BlackRock (BLK) gained marginally ahead of the opening bell, after the world's largest asset manager delivered better-than-expected quarterly earnings on the back of solid fee growth. Moreover, BlackRock (BLK) chief executive Larry Fink noted that long-term net inflows of $76.4B in the quarter already represented "nearly 40% of full year 2023 levels." Recently, Fink's dual role as chairman and CEO has come under scrutiny, with activist investor Bluebell Capital Partners last week launching a shareholder proposal for an independent chair. See how BLK performed in charts.
• State Street (STT) stock added around 1.5% ahead of market open, after the company reported a record $4.3T in assets under management at the end of Q1 2024. The Boston, Mass.-based asset manager's quarterly net interest income slipped 7% Y/Y, though total fee revenue rose 4% to $2.42B. "Fee revenue growth, on a year-over-year basis, reflected robust performance across our Global Advisors and Front office solutions businesses, which, along with growth in Servicing fees, more than offset lower trading revenues as volatility remained muted," State Street (STT) CEO Ron O'Hanley said.
• U.S.-listed shares of Novo Nordisk (NVO) climbed more than 1% in pre-market trading. The uptick came after Europe's drug regulator concluded a months-long review and said that there was no link between suicidal thoughts and weight loss GLP-1 agonists such as Novo's (NVO) semaglutide. Based on its own investigations and electronic health records of patients with overweight and type 2 diabetes who received the drugs, the European Medicines Agency said that the results "did not support a causal association between the use of GLP-1 receptor agonists and this risk."

More on the markets 

• Biggest stock movers today: NRIX and APLD
• LPCN, ADIL and CADL among pre-market losers
• Global Market Perspectives Q2 2024: What's Not To Like?
• Flash Insights: March Inflation - Yet Another Reason To Delay Easing
• Tighter Fundamentals And Geopolitics Are Pushing Commodities Higher